426 related articles for article (PubMed ID: 31552546)
1. Dendritic cells generated in the presence of interferon-α and modulated with dexamethasone as a novel tolerogenic vaccine platform.
Leplina O; Kurochkina Y; Tikhonova M; Shevela E; Ostanin A; Chernykh E
Inflammopharmacology; 2020 Feb; 28(1):311-319. PubMed ID: 31552546
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potential.
Leplina OY; Tyrinova TV; Tikhonova MA; Ostanin AA; Chernykh ER
Cytokine; 2015 Jan; 71(1):1-7. PubMed ID: 25174880
[TBL] [Abstract][Full Text] [Related]
3. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells.
Radvanyi LG; Banerjee A; Weir M; Messner H
Scand J Immunol; 1999 Nov; 50(5):499-509. PubMed ID: 10564553
[TBL] [Abstract][Full Text] [Related]
4. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.
Della Bella S; Nicola S; Riva A; Biasin M; Clerici M; Villa ML
J Leukoc Biol; 2004 Jan; 75(1):106-16. PubMed ID: 14525963
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.
Dauer M; Pohl K; Obermaier B; Meskendahl T; Röbe J; Schnurr M; Endres S; Eigler A
Immunology; 2003 Sep; 110(1):38-47. PubMed ID: 12941139
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells.
Bosma BM; Metselaar HJ; Nagtzaam NM; de Haan R; Mancham S; van der Laan LJ; Kuipers EJ; Kwekkeboom J
Immunology; 2008 Sep; 125(1):91-100. PubMed ID: 18312359
[TBL] [Abstract][Full Text] [Related]
7. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
[TBL] [Abstract][Full Text] [Related]
8. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells.
Farkas A; Tonel G; Nestle FO
Br J Dermatol; 2008 May; 158(5):921-9. PubMed ID: 18371115
[TBL] [Abstract][Full Text] [Related]
11. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
12. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
Dzopalic T; Dragicevic A; Vasilijic S; Vucevic D; Majstorovic I; Bozic B; Balint B; Colic M
Int Immunopharmacol; 2010 Nov; 10(11):1428-33. PubMed ID: 20817120
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
[TBL] [Abstract][Full Text] [Related]
14. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
[TBL] [Abstract][Full Text] [Related]
15. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
16. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
17. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone.
Lee JH; Park CS; Jang S; Kim JW; Kim SH; Song S; Kim K; Lee CK
Sci Rep; 2017 Nov; 7(1):15087. PubMed ID: 29118423
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
